Loading clinical trials...
Loading clinical trials...
to determine safety, efficacy and tolerability of BI 1356 versus placebo
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Boehringer Ingelheim
NCT06513026 · Lactose Intolerance, Lactose Intolerant, and more
NCT07112339 · Diabetes Mellitus, Type 2
NCT06329375 · Diabetes Mellitus, Type 2, Food Insecurity, and more
NCT06945406 · Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
NCT06959901 · Obesity and Diabetes Mellitus, Type 2, Diabetes Prevention
1218.43.10027 Boehringer Ingelheim Investigational Site
Phoenix, Arizona
1218.43.10011 Boehringer Ingelheim Investigational Site
Chula Vista, California
1218.43.10006 Boehringer Ingelheim Investigational Site
Riverside, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions